Dr. Gill Black is the co-founder and Director of Health and Welfare at The Sustainable Livelihoods Foundation (SLF). In this inteview, we discuss with Dr. Black one of SLF's groundbreaking projects that uses drama to engage local communities around ...
Listing to Podcast
Announcing the InnovateTB contest! Innovations are revolutionizing TB. Tell us your story! On World TB Day, the Stop TB Partnership Working Group on New TB Drugs (WGND) announces the InnovateTB Contest to encourage and highlight innovations to achiev...
Watch Video
In this week's interview, we discuss with Dr. Tawanda Gumbo his recently published paper that puts forth evidence that nonadherence may not be the prime reason for the emergence of drug resistance in TB, his research interests and background, the rec...
Listing to Podcast
The Kick TB Campaign is a unique project that uses the World's most popular sport to educate and engage young people in the effort to stop the spread of tuberculosis (TB). ...
Watch VideoDeadline Saturday, May 26, 2012. Click on InTB in menu or go to http://www.newtbdrugs.org/innovatetb/.
Go to “Resources” and then “Grants Finder” in menu or click here.
A briefing and update on tuberculosis (TB), a disease that is curable but still takes the lives of 4,000 people each day and is the number one killer of people living with HIV. Links to video included.
The latest news from the Stop TB Partnership as of April 2012.
An online tool that invites developers to submit their discovery programs so we can provide a more complete snapshot of current global efforts.
View Pipeline
An online tool that invites developers to submit their TB drug candidates so we can provide a more complete snapshot of current global efforts.
View Pipeline
A growing collection of resources to help access Tools, Knowledge, Facilities, and People in the TB drug development R&D community.
View TB ResourcesToday's TB drug regimen takes too long to be effective and requires too many medications. Treatment of drug-sensitive disease requires 6-9 months whereas treatment of drug-resistant TB is even lengthier, taking 18-24 months or longer.
Read More
To accelerate the discovery and development of new drugs for the treatment of tuberculosis by bringing together the stakeholders in TB Drug Development, including the patients themselves.
Read More »
The WGND is composed of diverse interested stakeholders in TB drug development, including those working in TB drug R&D, regulators, public health workers, funders, community representatives, advocates and policy-makers.
Read More »